XENE Q4 2025 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$611,000

Operating Income

-$110M

Net Income

-$105M

EPS (Diluted)

$-1.31

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$81M

Free Cash Flow

-$82M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$633M

Total Liabilities

$51M

Stockholders' Equity

$582M

Cash & Equivalents

$199M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$611,000	$0	—
Operating Income	-$110M	-$77M	-41.7%
Net Income	-$105M	-$66M	-60.3%